|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.60 EUR | -3.16% |
|
-7.96% | -6.86% |
| Jan. 13 | Teleperformance: stock hit after Concentrix announces losses | |
| Nov. 26 | Shouldn't have invited them: Teleperformance |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.58 | 7.06 | 7.32 | 6.32 | 5.74 | |||||
Return on Total Capital | 6.85 | 8.77 | 9.15 | 7.77 | 7.22 | |||||
Return On Equity % | 13.02 | 20.01 | 18.89 | 15.23 | 11.91 | |||||
Return on Common Equity | 13.02 | 20.01 | 18.89 | 15.24 | 11.92 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.67 | 30.34 | 32.6 | 31.27 | 31.63 | |||||
SG&A Margin | 10.09 | 9.42 | 10.88 | 9.78 | 12.03 | |||||
EBITDA Margin % | 15.65 | 16.26 | 16.84 | 16.85 | 15.35 | |||||
EBITA Margin % | 12.49 | 13.55 | 13.93 | 14.06 | 12.82 | |||||
EBIT Margin % | 10.84 | 12.17 | 12.36 | 12.51 | 10.78 | |||||
Income From Continuing Operations Margin % | 5.65 | 7.83 | 7.91 | 7.21 | 5.09 | |||||
Net Income Margin % | 5.65 | 7.83 | 7.91 | 7.21 | 5.09 | |||||
Net Avail. For Common Margin % | 5.65 | 7.83 | 7.91 | 7.21 | 5.09 | |||||
Normalized Net Income Margin | 5.81 | 6.88 | 7.04 | 6.49 | 5.45 | |||||
Levered Free Cash Flow Margin | 12.35 | 12.01 | 11.51 | 8.64 | 14.05 | |||||
Unlevered Free Cash Flow Margin | 13.21 | 12.67 | 12.25 | 9.77 | 15.63 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.82 | 0.93 | 0.95 | 0.81 | 0.85 | |||||
Fixed Assets Turnover | 4.67 | 5.91 | 6.65 | 6.2 | 7.35 | |||||
Receivables Turnover (Average Receivables) | 4.53 | 4.93 | 4.96 | 4.35 | 4.75 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.63 | 1.36 | 1.27 | 1.33 | 1.12 | |||||
Quick Ratio | 1.55 | 1.3 | 1.2 | 1.24 | 1.06 | |||||
Operating Cash Flow to Current Liabilities | 0.6 | 0.56 | 0.57 | 0.51 | 0.54 | |||||
Days Sales Outstanding (Average Receivables) | 80.77 | 74.05 | 73.57 | 83.96 | 77.08 | |||||
Average Days Payable Outstanding | 18.42 | 18.67 | 17 | 18.01 | 17.11 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 135.74 | 110.96 | 93.76 | 128.44 | 108.71 | |||||
Total Debt / Total Capital | 57.58 | 52.6 | 48.39 | 56.22 | 52.09 | |||||
LT Debt/Equity | 112.41 | 88.22 | 69.58 | 104.48 | 78.73 | |||||
Long-Term Debt / Total Capital | 47.68 | 41.82 | 35.91 | 45.74 | 37.72 | |||||
Total Liabilities / Total Assets | 65.7 | 62.01 | 58.57 | 63.95 | 62.27 | |||||
EBIT / Interest Expense | 7.86 | 11.55 | 10.39 | 6.91 | 4.26 | |||||
EBITDA / Interest Expense | 13.74 | 17.92 | 16.29 | 10.76 | 7.09 | |||||
(EBITDA - Capex) / Interest Expense | 10.47 | 14.83 | 13.22 | 9.22 | 6.25 | |||||
Total Debt / EBITDA | 3.01 | 2.61 | 2.18 | 3.35 | 2.69 | |||||
Net Debt / EBITDA | 2.1 | 1.98 | 1.66 | 2.81 | 2.11 | |||||
Total Debt / (EBITDA - Capex) | 3.95 | 3.15 | 2.69 | 3.91 | 3.05 | |||||
Net Debt / (EBITDA - Capex) | 2.75 | 2.4 | 2.05 | 3.28 | 2.4 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 7.04 | 24.13 | 14.61 | 2.34 | 23.19 | |||||
Gross Profit, 1 Yr. Growth % | 0.34 | 22.81 | 22.51 | -1.85 | 24.65 | |||||
EBITDA, 1 Yr. Growth % | 0.36 | 34.81 | 17.96 | 2.48 | 14.35 | |||||
EBITA, 1 Yr. Growth % | -1.76 | 42.34 | 16.99 | 3.35 | 14.91 | |||||
EBIT, 1 Yr. Growth % | -1.4 | 48.73 | 15.46 | 3.78 | 10.25 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -19 | 71.91 | 15.8 | -6.38 | -11.66 | |||||
Net Income, 1 Yr. Growth % | -19 | 71.91 | 15.8 | -6.38 | -11.66 | |||||
Normalized Net Income, 1 Yr. Growth % | -1.26 | 58.42 | 16.2 | -5.46 | 8.34 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -18.97 | 69.62 | 15.38 | -5.48 | -12.99 | |||||
Accounts Receivable, 1 Yr. Growth % | 6.87 | 20.89 | 8.04 | 24.9 | 3.29 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -6.16 | 2.44 | 2.14 | 17.19 | -7.7 | |||||
Total Assets, 1 Yr. Growth % | 1.94 | 18.31 | 6.21 | 32.17 | 0.05 | |||||
Tangible Book Value, 1 Yr. Growth % | -29.1 | 58.02 | -20.19 | 151.08 | -14.18 | |||||
Common Equity, 1 Yr. Growth % | -6.19 | 31.05 | 16.31 | 15.31 | 8.01 | |||||
Cash From Operations, 1 Yr. Growth % | 20.46 | 15.37 | 13.41 | 6.26 | 31.85 | |||||
Capital Expenditures, 1 Yr. Growth % | 2.38 | -10.08 | 28.45 | -21.81 | -6.01 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 69.15 | 24.99 | 9.27 | -23.21 | 86.38 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 57.84 | 22.97 | 10.31 | -18.43 | 84.84 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 37.5 | 16.67 | 0 | 9.09 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 13.61 | 15.27 | 19.27 | 8.3 | 12.28 | |||||
Gross Profit, 2 Yr. CAGR % | 10.65 | 11.01 | 22.97 | 9.66 | 10.6 | |||||
EBITDA, 2 Yr. CAGR % | 12.41 | 13.76 | 26.49 | 9.9 | 7.24 | |||||
EBITA, 2 Yr. CAGR % | 11.9 | 14.99 | 29.52 | 9.91 | 7.76 | |||||
EBIT, 2 Yr. CAGR % | 12.25 | 17.24 | 31.58 | 9.36 | 4.95 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 1.74 | 18 | 41.09 | 3.96 | -9.81 | |||||
Net Income, 2 Yr. CAGR % | 1.9 | 18 | 41.09 | 3.96 | -9.81 | |||||
Normalized Net Income, 2 Yr. CAGR % | 9.91 | 20.41 | 36.29 | 4.7 | -1.1 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 2.14 | 17.24 | 39.9 | 4.29 | -10.07 | |||||
Accounts Receivable, 2 Yr. CAGR % | 11.68 | 13.66 | 14.28 | 16.16 | 13.53 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 54.67 | -1.95 | 2.08 | 9.41 | 4.07 | |||||
Total Assets, 2 Yr. CAGR % | 9.22 | 9.82 | 12.34 | 18.67 | 16.52 | |||||
Tangible Book Value, 2 Yr. CAGR % | -29.88 | 5.85 | 14.53 | 44.12 | 57.05 | |||||
Common Equity, 2 Yr. CAGR % | 4.24 | 10.88 | 23.46 | 15.78 | 11.42 | |||||
Cash From Operations, 2 Yr. CAGR % | 37.51 | 17.89 | 14.38 | 9.78 | 18.37 | |||||
Capital Expenditures, 2 Yr. CAGR % | 14.44 | -4.05 | 7.47 | 0.22 | -14.27 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 111.25 | 42.88 | 17.17 | -8.36 | 24 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 96.5 | 37.06 | 16.75 | -5.11 | 26.76 | |||||
Dividend Per Share, 2 Yr. CAGR % | 12.39 | 17.26 | 26.66 | 8.01 | 4.45 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.1 | 17.01 | 15.05 | 13.34 | 13.05 | |||||
Gross Profit, 3 Yr. CAGR % | 7.03 | 14.56 | 14.91 | 14.07 | 14.44 | |||||
EBITDA, 3 Yr. CAGR % | 10.44 | 17.67 | 15.37 | 17.89 | 10.68 | |||||
EBITA, 3 Yr. CAGR % | 11.05 | 19 | 15.94 | 20.1 | 10.72 | |||||
EBIT, 3 Yr. CAGR % | 11.76 | 20.65 | 16.96 | 21.49 | 8.27 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 1.05 | 21.18 | 17.26 | 22.94 | -2.08 | |||||
Net Income, 3 Yr. CAGR % | 1.27 | 21.31 | 17.26 | 22.94 | -2.08 | |||||
Normalized Net Income, 3 Yr. CAGR % | 10.82 | 21.05 | 19.35 | 20.56 | 4.29 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 1.29 | 20.95 | 16.62 | 22.64 | -2.37 | |||||
Accounts Receivable, 3 Yr. CAGR % | 13.41 | 14.67 | 11.76 | 17.72 | 11.67 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 41.13 | 34.82 | -0.74 | 6.89 | 3.43 | |||||
Total Assets, 3 Yr. CAGR % | 16.09 | 12.17 | 8.76 | 18.72 | 13.1 | |||||
Tangible Book Value, 3 Yr. CAGR % | -3.09 | -8.07 | -2.39 | 50.57 | 26.83 | |||||
Common Equity, 3 Yr. CAGR % | 8.04 | 12.5 | 12.66 | 20.66 | 13.01 | |||||
Cash From Operations, 3 Yr. CAGR % | 24.22 | 29.7 | 16.38 | 11.61 | 16.69 | |||||
Capital Expenditures, 3 Yr. CAGR % | 20.35 | 5.6 | 5.75 | -3.34 | -1.9 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 22.99 | 75.29 | 30.89 | 1.8 | 18.91 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 22.58 | 66.25 | 27.7 | 3.62 | 21.05 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.06 | 20.2 | 17.06 | 17.06 | 8.37 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.02 | 14.29 | 14.3 | 13.45 | 13.93 | |||||
Gross Profit, 5 Yr. CAGR % | 9.59 | 12.2 | 13.14 | 12.69 | 13.17 | |||||
EBITDA, 5 Yr. CAGR % | 14.49 | 17.48 | 15.57 | 14.64 | 12.04 | |||||
EBITA, 5 Yr. CAGR % | 16.69 | 20.02 | 16.78 | 15.45 | 12.57 | |||||
EBIT, 5 Yr. CAGR % | 15.06 | 20.21 | 17.77 | 16.19 | 11.95 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.8 | 20.75 | 15.49 | 13.98 | 5.51 | |||||
Net Income, 5 Yr. CAGR % | 10.13 | 21.08 | 15.63 | 14.05 | 5.51 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.06 | 21.05 | 18.56 | 14.43 | 10.66 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.85 | 20.59 | 15.26 | 13.99 | 5.04 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.63 | 12.65 | 13.76 | 15.26 | 12.46 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 22.67 | 20.67 | 23.98 | 23.91 | 1.16 | |||||
Total Assets, 5 Yr. CAGR % | 17.78 | 10.72 | 14.57 | 14.83 | 11.87 | |||||
Tangible Book Value, 5 Yr. CAGR % | 12.85 | -3.11 | 3.61 | 10.91 | 18.91 | |||||
Common Equity, 5 Yr. CAGR % | 6.5 | 10.56 | 13.97 | 13.8 | 12.15 | |||||
Cash From Operations, 5 Yr. CAGR % | 20.39 | 19.98 | 20.19 | 21.33 | 17.17 | |||||
Capital Expenditures, 5 Yr. CAGR % | 8.2 | 3.86 | 15.02 | 3.41 | -2.77 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 32.53 | 38.32 | 19.79 | 35.37 | 28.11 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 32.2 | 36.44 | 19.43 | 32.98 | 27.34 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.87 | 20.48 | 15.79 | 15.17 | 11.84 |
- Stock Market
- Equities
- TEP Stock
- Financials Teleperformance SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















